EIF2AK4 and neoplasm: Immunohistochemical analyses of harvested tumours confirmed downregulation of NCP26 targets, including MYC, CCND1 and TCF3, and ISR engagement, evidenced by induction of p-GCN2 and DDIT3 (Fig. 5D).